ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,042Medicare Part D Prescriptions Filled, Including Refills

Rank: 193 out of 3593

$1M Total Retail Price of All Prescriptions

Rank: 129 out of 3593

423 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
82% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 423 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

21% of this provider’s 423 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 15,128 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

40 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
LEVOTHYROXINE SODIUM 634 589 1 4
FUROSEMIDE 529 509 2 9
WARFARIN SODIUM 466 433 3 18
LISINOPRIL 426 397 4 2
NAMENDA 398 398 5 50
HYDROCODONE-ACETAMINOPHEN 377 318 S3 6 7
SIMVASTATIN 376 309 7 1
DONEPEZIL HCL 369 362 8 31
CITALOPRAM HBR 343 315 9 25
POTASSIUM CHLORIDE 342 317 10 24
GABAPENTIN 330 293 11 16
AMLODIPINE BESYLATE 320 309 12 3
METOPROLOL TARTRATE 312 300 13 8
MIRTAZAPINE 307 268 14 64
METFORMIN HCL 297 285 15 6
OMEPRAZOLE 280 251 16 5
QUETIAPINE FUMARATE 188 157 17 89
TRAMADOL HCL 182 174 18 17
LEVOFLOXACIN 174 148 19 116
RISPERIDONE 167 163 20 83
CARBIDOPA-LEVODOPA 163 147 21 135
LANTUS 150 144 22 57
DIGOXIN 150 146 22 58
SERTRALINE HCL 148 134 24 28
RANITIDINE HCL 146 142 25 27
CYMBALTA 133 88 26 73
CARVEDILOL 126 103 27 23
TAMSULOSIN HCL 123 121 28 33
TRIAMCINOLONE ACETONIDE 123 107 28 119
DIVALPROEX SODIUM 118 97 30 121
IPRATROPIUM-ALBUTEROL 117 113 31 154
ATORVASTATIN CALCIUM 114 109 32 15
EXELON 112 112 33 123
ESCITALOPRAM OXALATE 112 103 33 71
RAMIPRIL 110 109 35 92
TRAZODONE HCL 109 75 36 53
PREDNISONE 108 93 37 49
CLOPIDOGREL 107 107 38 30
AZITHROMYCIN 106 99 39 34
BACLOFEN 101 64 40 109
NOVOLIN R 98 98 41 140
METOPROLOL SUCCINATE 97 86 42 19
ISOSORBIDE MONONITRATE ER 95 93 43 61
LYRICA 91 62 44 105
LEVETIRACETAM 89 45 45 127
ADVAIR DISKUS 88 71 46 47
NOVOLOG 86 80 47 134
BUMETANIDE 86 63 47 148
PLAVIX 85 85 49 42
ATENOLOL 83 68 50 11
ALENDRONATE SODIUM 80 71 51 22
SULFAMETHOXAZOLE-TRIMETHOPRIM 79 66 52 102
MORPHINE SULFATE ER 78 54 S2 53 108
SANTYL 77 72 54 208
CEPHALEXIN 75 69 55 150
MUPIROCIN 75 54 55 132
BENZTROPINE MESYLATE 75 52 R 55 202
CIPROFLOXACIN HCL 74 68 58 52
FENTANYL 73 63 S2 59 137
LOVASTATIN 71 70 60 20
KLOR-CON M20 70 55 61 139
ZOLPIDEM TARTRATE 69 65 62 12
LIDODERM 69 68 62 78
SPIRONOLACTONE 69 50 62 86
ALLOPURINOL 69 69 62 35
PHENYTOIN 67 36 66 326
HYDROCHLOROTHIAZIDE 67 61 66 10
GLIMEPIRIDE 67 67 66 44
ALBUTEROL SULFATE 67 63 66 157
GLIPIZIDE 66 64 70 40
GLYBURIDE 64 51 R 71 55
SEROQUEL 64 59 71 172
LATANOPROST 64 64 71 195
HYDRALAZINE HCL 64 52 71 107
PRAVASTATIN SODIUM 64 50 71 13
ROPINIROLE HCL 60 42 76 144
TRILIPIX 59 59 77 233
METHYLPREDNISOLONE 59 56 77 103
SPIRIVA 58 58 79 87
TORSEMIDE 57 57 80 218
GENERLAC 56 35 81 271
CRESTOR 55 45 82 21
AMIODARONE HCL 54 54 83 269
METRONIDAZOLE 52 46 84 268
NYSTOP 51 41 85 309
ENALAPRIL MALEATE 50 45 86 38
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 23, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.